Top 5 Wine And Spirits VC (Venture Capital) Funds in Germany in October 2023

Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.

Investment focus

Software, Artificial Intelligence, E-Commerce
Pre-Seed, Seed, Funding Round
United States, Canada, United Kingdom

Portfolio highlights

InSyBio — A disruptor to Precision Medicine and Nutrition through biomarker discovery.
ZestIOT — ZestIOT is an IoT & AI enabled aviation platform to integrate passenger, baggage, aircraft, ground & airport operations.
Wellx — Turn your health into currency. At Wellx, we're focused on making you healthier. Insurance helps us make it happen.

Show more investments...

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Germany, United Kingdom

Portfolio highlights

Doctorflix — Doctorflix is a medical education platform that allows doctors around the globe to learn about methods of treatment while accelerating their system-required professional development. We are on a mission to build an engine that simplifies and democratizes the consumption and exchange of medical knowledge by interlinking doctors, hospitals, andpharmaceutical companies.
mama health — mama health is a platform to find others around the world living the same journey as you - and learn form each other's experience.
DearEmployee — DearEmployee is the Workplace Mental Health Platform. As a corporate health start-up, we support employers in designing healthy and motivating working conditions for their employees in order to reduce mental stress and to increase employee productivity. Using the DearEmployee platform, companies can easily and digitally measure mental stress at theworkplace in a scientific way, and subsequently sign up to tailored health and HR measures. The solution also meets the legal requirements for mental health risk assessment in Germany.

Show more investments...

We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage

Investment focus

Software, SaaS, E-Commerce
Seed, Series A, Funding Round
Germany, United States, Poland

Portfolio highlights

Hero — Hero is a B2B payments and financing platform, offer direct online payment experience and receive your money immediately.
Otterspace — Otterspace takes care of DAOs.
Flinn Comply — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.

Show more investments...

Ace Ventures was designed to help new ideas, smart people and great companies to successfully enter the Internet business in Germany.

Investment focus

Apps, Wedding, Internet
Seed, Series A, Series B
United States, Germany, Italy

Portfolio highlights

iMediSync — iMediSync provides automatic brain wave analysis and neuromodulation solutions.
Joy — Experience wedding planning the way it should be, from beautiful wedding websites and invitations, to registries and online RSVP.
Kither Biotech — Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.

Show more investments...